Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 164 participants.
Also called NCT07751965
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 164 participants
- Sponsor
- Registry
-
NCT07751965
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07751965. Allocation not applicable; no masking; primary purpose treatment. Start 2026-10-30 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR
- Acronym
- MARVELTAVI
- Condition
- Aortic Regurgitation
- Condition
- Aortic Disease
- Condition
- Calcified Aortic Valve
- Intervention (Device)
- Myval THV series
- Lead sponsor
- Ceric Sàrl
Record details
- Record id
cardio:ct-nct07751965- Content hash
930c4cb74c9572b357bbdebf22876ba0926e822f5e8168fb0f449593fb3c23cb